Erythropoietic agents in routine clinical practice: a retrospective observational survey of epoetin alfa, epoetin beta and darbepoetin alfa use in anaemia patients with cancer

被引：0
|
作者：
Pujade-Lauraine, Eric [1 ]
Richard, Alain J. [2 ]
Sapede, Claudine [3 ]
机构：
[1] CHU, Hotel Dieu, Serv Oncol, Paris, France
[2] GECEM SA, Paris, France
[3] F Hoffmann La Roche & Cie AG, PBSE, Basel, Switzerland
来源：
ANNALS OF ONCOLOGY | 2004年 / 15卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：220 / 220
页数：1
相关论文
共 50 条
  • [1] Erythropoietic agents in anaemic patients with cancer:: A retrospective observational survey of epoetin α, epoetin β and darbepoetin a use in routine clinical practice
    Pujade-Lauraine, E
    Richard, AJ
    Sapede, C
    Hayward, C
    ONCOLOGY REPORTS, 2005, 14 (04) : 1037 - 1044
  • [2] Use of darbepoetin alfa and epoetin alfa in clinical practice in patients with cancer-related anemia
    Berger, Arlel
    Edelsberg, John
    Kallich, Joel
    Oster, Gerry
    CLINICAL THERAPEUTICS, 2008, 30 (01) : 206 - 218
  • [3] A systematic review and economic evaluation of epoetin alfa, epoetin beta and darbepoetin alfa in anaemia associated with cancer, especially that attributable to cancer treatment
    Wilson, J.
    Yao, G. L.
    Raftery, J.
    Bohlius, J.
    Brunskill, S.
    Sandercock, J.
    Bayliss, S.
    Moss, P.
    Stanworth, S.
    Hyde, C.
    HEALTH TECHNOLOGY ASSESSMENT, 2007, 11 (13) : 1 - +
  • [4] An audit comparing epoetin alfa/beta to darbepoetin alfa in hemodialysis patients
    Glueck, Zeev
    Zuercher, Alfred
    Von Schack, Bettina
    Zysset, Thomas
    Saldutto, Biagio
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2006, 21 : 153 - 154
  • [5] Retrospective study of the appropriate utilization of epoetin alfa and darbepoetin alfa in cancer patients with anemia
    Wong, SF
    Brown, ML
    Sarkisian, R
    PHARMACOTHERAPY, 2004, 24 (10): : 1452 - 1452
  • [6] Clinical Practice guidelines for the use of erythropoiesis-stimulating agents (ESA:: epoetin alfa, epoetin beta, darbepoetin) in anaemic patients with cancer:: 2007 update (summary report)
    Ray-Coquard, Isabelle
    Kassab-Chahmi, Diana
    Casadevall, Nicole
    Chastagner, Pascal
    Marchal, Christian
    Marec-Berard, Purrine
    Misset, Jean-Louis
    BULLETIN DU CANCER, 2008, 95 (04) : 433 - 441
  • [7] Epoetin Alfa and Darbepoetin Alfa in Clinical Practice in Patients With Chemotherapy Induced Anemia in the Netherlands (EVALUATE)
    van Groeningen, C. J.
    Kok, T. C.
    Biesma, B.
    Melissant, C. F.
    de Klerk, G.
    Brok, R. G. P. M.
    Lahaye, M.
    Milek, R. L. B.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S237 - S237
  • [8] Use and outcomes of epoetin alfa and darbepoetin alfa for anemic cancer patients in outpatient community practice settings.
    Fahrbach, KR
    Frame, D
    Sercus, B
    Schenkel, B
    BLOOD, 2005, 106 (11) : 485B - 486B
  • [9] Utilization and Cost in Clinical Practice of Darbepoetin Alfa and Epoetin Alfa for Anemia Concomitant With Chemotherapy
    Berger, Ariel
    Lord, Claudia
    Corey-Lisle, Patricia K.
    Williams, G. Rhys
    Oster, Gerry
    CLINICAL THERAPEUTICS, 2012, 34 (06) : 1350 - 1363
  • [10] Cost comparison of epoetin alpha, epoetin beta and darbepoetin alpha for cancer patients with anaemia in the clinical practice setting
    Reichardt, B.
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2006, 31 (05) : 503 - 512
12345